Clinical trial
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly…
NCT00394628 · Novacea, Industry · Unknown status
Key facts
| NCT number | NCT00394628 |
|---|---|
| Title | AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme |
| Official title | A Phase 1b/2a, Multicenter, Open-Label Study of AQ4N in Combination With Radiation Therapy and Temozolomide, to Evaluate the Safety, Tolerability, and Efficacy in Subjects With Newly Diagnosed Glioblastoma Multiforme |
| Lead sponsor | Novacea, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Glioblastoma Multiforme |
| Intervention type | Drug, Procedure |
| Interventions | AQ4N, Temozolomide, Radiotherapy |
| Enrollment | 60 |
| Start date | Oct 1, 2006 |
| First posted | Nov 1, 2006 |
| Last update posted | May 30, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: